References
- Williams TN, Weatherall DJ. World distribution, population genetics, and health burden of the hemoglobinopathies. Cold Spring Harb Perspect Med. 2012;2(9):a011692 doi: 10.1101/cshperspect.a011692.
- Giardine B, Borg J, Viennas E, et al. Updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res. 2014;42(Database issue):D1063–D1069 (http://globin.cse.psu.edu).
- Fonseca SF, MouraNeto JP, Goncalves MS. Prevalence and molecular characterization of β-thalassemia in the state of Bahia, Brazil: First identification of mutation HBB: c.135delC in Brazil. Hemoglobin. 2013;37(3):285–290.
- Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):480–487.
- Weatherall DJ. Hemoglobinopathies worldwide: Present and future. Curr Mol Med. 2008;8(7):592–599.
- Weatherall DJ, Clegg JB. The Thalassaemia Syndromes, 4th ed. Oxford, UK: Blackwell Science, 2001.
- Rund D, Rachmilewitz E. β-thalassemia. N Engl J Med. 2005;353(11):1135–1146.
- Li CG, Li CF, Li Q, Li M. Thalassemia incidence and treatment in China with special reference to Shenzhen City and Guangdong Province. Hemoglobin. 2009;33(5):296–303.
- van den Broek NR, Letsky EA, White SA, Shenkin A. Iron status in pregnant women: Which measurements are valid. Br J Haematol. 1998;103(3):817–824.
- Blackmore S, Hamilton M, Lee A, et al. Automated immunoassay methods for ferritin: recovery studies to assess traceability to an international standard. Clin Chem Lab Med. 2008;46(10):1450–1457.
- Perrota G. Iron and iron-binding capacity. In: Pesce AJ, Kaplan LA, Eds. Methods in Clinical Chemistry. St. Louis, MO, USA: C.V. Mosby. 1987:1258–1261.
- Yang Z, Chaffin CH, Easley PL, et al. Prevalence of elevated Hemoglobin A2 measured by the CAPILLARYS system. Am J Clin Pathol. 2009;131(1):42–48.
- Landers JP. Clinical capillary electrophoresis. Clin Chem. 1995;41(4):495–509.
- Pornprasert S, Panyasai S, Treesuwan K. Unmasking Hb Paksé (codon 142, TAA>TAT, α2) and its combinations in patients also carrying Hb Constant Spring (codon 142, TAA>CAA, α2) in northern Thailand. Hemoglobin. 2012;36(5):491–496.
- He X, Sheng M, Xu M, et al. Rapid identification of common β-thalassemia mutations in the Chinese population using duplex or triplex amplicon genotyping by high-resolution melting analysis. Genet Test Mol Biomarkers. 2010;14(6):851–856.
- Shih HG, Er TK, Chang TJ, et al. Rapid identification of HBB gene mutations by high-resolution melting analysis. Clin Biochem. 2009;42(16-17):1667–1676.
- Lin M, Zhong TY, Chen YG, et al. Molecular epidemiological characterization and health burden of thalassemia in Jiangxi Province, P. R. China. PLoS One. 2014;9(7):e101505. doi:10.1371/journal.pone.0101505.
- Xiong F, Sun M, Zhang X, et al. Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China. Clin Genet. 2010;78(2):139–148.
- Xu XM, Zhou YQ, Luo GX, et al. The prevalence and spectrum of α and β thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol. 2004;57(5):517–522.
- Pasricha S-R, Drakesmith H, Black J, et al. Control of iron deficiency anemia in low- and middle-income countries. Blood. 2013;121(14):2607–2617.
- Usman M, Moinuddin M, Ahmed SA. Role of iron deficiency anemia in the propagation of β thalssemia gene. Korean J Hematol. 2011;46(1):41–44.
- Behan KJ, Storey NM, Lee HK. Reporting variant hemoglobins discovered during Hemoglobin A1c analysis – Common practices in clinical laboratories. Clin Chim Acta. 2009;406(1-2):124–128.
- Rosenbloom KR, Sloan CA, Malladi VS, et al. PhenCode: Connecting ENCODE data with mutations and phenotype. Hum Mutat. 2007;28(6):554–562.